Literature DB >> 14984475

Germline-sequence variants S836S and L769L in the RE arranged during Transfection (RET) proto-oncogene are not associated with predisposition to sporadic medullary carcinoma in the French population.

I Berard, J-L Kraimps, F Savagner, A Murat, K Renaudin, P Nicolli-Sire, G Bertrand, J-P Moisan, S Bezieau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14984475     DOI： 10.1111/j.0009-9163.2004.00172.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN： 0009-9163            Impact factor:   4.438


× No keyword cloud information.
  10 in total

1.  The frequency of selected polymorphic variants of the RET gene in patients with medullary thyroid carcinoma and in the general population of central Poland.

Authors:  Maria Sromek; Malgorzata Czetwertyńska; Elzbieta Skasko; Joanna Zielińska; Dorota Czapczak; Jan Steffen
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

2.  Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients.

Authors:  A Gursoy; M F Erdogan; G Erdogan
Journal:  J Endocrinol Invest       Date:  2006-11       Impact factor: 4.256

3.  Quantitative assessment of the association between L769L and S836S polymorphisms at RET gene and medullary thyroid carcinoma risk.

Authors:  Yuanqi Zhang; Sanming Wang; Xiaodong Chen; Shengchao Huang; Jianwen Li
Journal:  Tumour Biol       Date:  2014-04-04

Review 4.  Molecular basis of medullary thyroid carcinoma: the role of RET polymorphisms.

Authors:  Lucieli Ceolin; Débora R Siqueira; Mírian Romitti; Carla V Ferreira; Ana Luiza Maia
Journal:  Int J Mol Sci       Date:  2011-12-27       Impact factor: 5.923

5.  Predominant RET Germline Mutations in Exons 10, 11, and 16 in Iranian Patients with Hereditary Medullary Thyroid Carcinoma.

Authors:  Mehdi Hedayati; Marjan Zarif Yeganeh; Sara Sheikhol Eslami; Shekoofe Rezghi Barez; Laleh Hoghooghi Rad; Fereidoun Azizi
Journal:  J Thyroid Res       Date:  2011-06-13

6.  RET polymorphisms and sporadic medullary thyroid carcinoma in a Portuguese population.

Authors:  Patrícia Costa; Rita Domingues; Luís G Sobrinho; Maria João Bugalho
Journal:  Endocrine       Date:  2005-08       Impact factor: 3.925

7.  Genetic risk association of CDKN1A and RET gene SNPs with medullary thyroid carcinoma: Results from the largest MTC cohort and meta-analysis.

Authors:  Vasudha Mishra; Pradnya Kowtal; Pallavi Rane; Rajiv Sarin
Journal:  Cancer Med       Date:  2019-08-13       Impact factor: 4.452

8.  RET Proto-Oncogene Mutational Analysis in 45 Iranian Patients Affected with Medullary Thyroid Carcinoma: Report of a New Variant.

Authors:  Elia Damavandi; Fatemeh Vand-Rajabpour; Maliheh Javadi-Arjmand; Mohammad-Reza Mohajeri Tehrani; Bagher Larijani; Majid Kabuli; Mohsen Ghadami
Journal:  J Thyroid Res       Date:  2021-11-03

9.  Over-representation of the G12S polymorphism of the SDHD gene in patients with MEN2A syndrome.

Authors:  Nikoletta Lendvai; Miklos Tóth; Zsuzsanna Valkusz; Gabriella Bekő; Nikolette Szücs; Eva Csajbók; Péter Igaz; Balázs Kriszt; Balázs Kovács; Károly Rácz; Attila Patócs
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

10.  Effect of 3'UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma.

Authors:  Lucieli Ceolin; Mirian Romitti; Débora Rodrigues Siqueira; Carla Vaz Ferreira; Jessica Oliboni Scapineli; Beatriz Assis-Brazil; Rodolfo Vieira Maximiano; Tauanne Dias Amarante; Miriam Celi de Souza Nunes; Gerald Weber; Ana Luiza Maia
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.